111
Participants
Start Date
February 13, 2020
Primary Completion Date
October 27, 2022
Study Completion Date
October 27, 2022
SKL24741
An inhibitor of voltage-gated sodium channels and a possible activator of Big Potassium channels. Administered as an oral dose in the form of a capsule or tablet.
Placebo
Sugar pill manufactured to mimic SKL24741
Spaulding Clinical Research, West Bend
Collaborators (1)
Spaulding Clinical Research LLC
OTHER
Covance
INDUSTRY
SK Life Science, Inc.
INDUSTRY